---
title: "Catalyst directors Patrick J. McEnany, Richard J. Daly and others to resign upon merger"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292117774.md"
description: "Catalyst Pharmaceuticals directors Patrick J. McEnany, Richard J. Daly, Daniel J. Curran, Donald A. Denkhaus, Molly Harper, Tamar Thompson, and David S. Tierney will resign from the board upon the closing of an anticipated merger."
datetime: "2026-07-08T21:33:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292117774.md)
  - [en](https://longbridge.com/en/news/292117774.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292117774.md)
generator: "portal-rs"
---

# Catalyst directors Patrick J. McEnany, Richard J. Daly and others to resign upon merger

**Catalyst directors Patrick J. McEnany, Richard J. Daly, Daniel J. Curran, Donald A. Denkhaus, Molly Harper, Tamar Thompson and David S. Tierney will resign from the board effective at the Merger's closing.**

Individual

Patrick J. McEnany

Richard J. Daly

Daniel J. Curran, M.D.

Donald A. Denkhaus

Molly Harper

Tamar Thompson

David S. Tierney, M.D.

Role

Director

Director

Director

Director

Director

Director

Director

Type of Change

Resignation (anticipated)

Resignation (anticipated)

Resignation (anticipated)

Resignation (anticipated)

Resignation (anticipated)

Resignation (anticipated)

Resignation (anticipated)

Effective Date

Effective as of the Merger's effective time

Effective as of the Merger's effective time

Effective as of the Merger's effective time

Effective as of the Merger's effective time

Effective as of the Merger's effective time

Effective as of the Merger's effective time

Effective as of the Merger's effective time

Reason

In connection with anticipated Merger

In connection with anticipated Merger

In connection with anticipated Merger

In connection with anticipated Merger

In connection with anticipated Merger

In connection with anticipated Merger

In connection with anticipated Merger

Replacement Info

Not disclosed

Not disclosed

Not disclosed

Not disclosed

Not disclosed

Not disclosed

Not disclosed

Background Details

Not disclosed

Not disclosed

Not disclosed

Not disclosed

Not disclosed

Not disclosed

Not disclosed

Board/Committee Role Changes

Resign from board and any committee thereof

Resign from board and any committee thereof

Resign from board and any committee thereof

Resign from board and any committee thereof

Resign from board and any committee thereof

Resign from board and any committee thereof

Resign from board and any committee thereof

Original SEC Filing: CATALYST PHARMACEUTICALS, INC. \[ CPRX \] - 8-K - Jul. 08, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [CPRX.US](https://longbridge.com/en/quote/CPRX.US.md)

## Related News & Research

- [Catalyst Pharmaceuticals directors resign; Merger Sub directors join board](https://longbridge.com/en/news/292887991.md)
- [Crinetics Pharmaceuticals Completes Merger and Delists Shares](https://longbridge.com/en/news/297680237.md)
- [Enterprise Ireland-backed Future Planet merges with Institute of Sustainability Studies to expand ESG platform](https://longbridge.com/en/news/297671534.md)
- [Merger to margins: How brokerages assess Sashidhar Jagdishan's tenure at HDFC Bank](https://longbridge.com/en/news/297454584.md)
- [Universe Pharmaceuticals fields shareholder questions ahead of Sept. 30 annual meeting](https://longbridge.com/en/news/297701139.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**